Literature DB >> 11466573

Molecular mechanisms in the early phase of hemorrhagic shock.

C Hierholzer1, T R Billiar.   

Abstract

Hemorrhagic shock (HS) results in the initiation of an inflammatory cascade that is critical for survival following successful resuscitation. We identified a complex sequence of molecular events including shock-dependent and reperfusion-dependent responses that offer a new comprehensive approach for consequences of HS. Shock-dependent initializing mechanisms include the induction of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, and CD14 and play a catalyzing role for subsequent phenotypic changes following resuscitation. The early immediate response genes iNOS and COX-2 promote the inflammatory response by the rapid and excessive production of nitric oxide (NO) and prostaglandins. The transcription factor hypoxia-inducible factor-1 (HIF-1) may regulate the induction of iNOS during the ischemic phase of shock. NO is an important signaling molecule which is involved in redox-sensitive mechanisms including the downstream activation of nuclear factor (NF)-kappaB. NO-dependent NF-kappaB activation promotes the induction of inflammatory cytokine expression during the reperfusion phase. Peroxynitrite-mediated direct toxicity and NO-mediated inflammatory toxicity contribute to organ injury. Patients suffering consequences of severe HS are susceptible to systemic inflammation, organ injury, and mortality if physiologic and therapeutic mechanisms are ineffective in limiting the activation of the inflammatory cascade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466573      PMCID: PMC7101685          DOI: 10.1007/s004230100242

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  47 in total

1.  Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.

Authors:  Yongqing Li; Hasan B Alam
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  A new model of severe hemorrhagic shock in rats.

Authors:  Thomas Rönn; Sven Lendemans; Herbert de Groot; Frank Petrat
Journal:  Comp Med       Date:  2011-10       Impact factor: 0.982

3.  Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival.

Authors:  Vivek R Yadav; Kaustuv Sahoo; Pamela R Roberts; Vibhudutta Awasthi
Journal:  J Pharmacol Exp Ther       Date:  2013-08-30       Impact factor: 4.030

Review 4.  [Treatment of hemorrhagic shock. New therapy options].

Authors:  W G Voelckel; A von Goedecke; D Fries; A C Krismer; V Wenzel; K H Lindner
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

5.  In silico and in vivo approach to elucidate the inflammatory complexity of CD14-deficient mice.

Authors:  Jose M Prince; Ryan M Levy; John Bartels; Arie Baratt; John M Kane; Claudio Lagoa; Jonathan Rubin; Judy Day; Joyce Wei; Mitchell P Fink; Sanna M Goyert; Gilles Clermont; Timothy R Billiar; Yoram Vodovotz
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

6.  A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.

Authors:  Tomoharu Shimizu; László Szalay; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 7.  Interaction between the coagulation and complement system.

Authors:  Umme Amara; Daniel Rittirsch; Michael Flierl; Uwe Bruckner; Andreas Klos; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  In vivo visualization of nitric oxide and interactions among platelets, leukocytes, and endothelium following hemorrhagic shock and reperfusion.

Authors:  Mie Hiratsuka; Tomihiro Katayama; Kazuhiko Uematsu; Masaki Kiyomura; Masaharu Ito
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

9.  Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation.

Authors:  David G Beiser; Huashan Wang; Jing Li; Xu Wang; Violeta Yordanova; Anshuman Das; Tamara Mirzapoiazova; Joe G N Garcia; Susan A Stern; Terry L Vanden Hoek
Journal:  Resuscitation       Date:  2010-03-26       Impact factor: 5.262

10.  Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury.

Authors:  Balázs Koscsó; Alexey Trepakov; Balázs Csóka; Zoltán H Németh; Pál Pacher; Holger K Eltzschig; György Haskó
Journal:  Purinergic Signal       Date:  2013-04-13       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.